As a ligand, the iRGD peptide can interact with tumor cells with high expression of the neuropilin-1 (NRP-1) receptor, mediate the cell membrane penetration effect, and effectively kill the tumor (Nie et al., 2014). Here, NRP1 is linked to neoplasm.